Why GLP-1 (semaglutide or tirzepatide) Might Be Particularly Relevant in Older Adults Cardiometabolic protection Large cardiovascular outcome trials (e.g., SELECT , SUSTAIN-6 ) show semaglutide reduces major adverse cardiovascular events (MACE), and subgroup analyses suggest these benefits extend to older patients
GLP-1 The 'that's enough' signal
Its impact on quality of life, however, can be disproportionately severe compared to its frequency
I felt heard and supported every step. Lost 50 lbs with Mochi Health Texas telehealth platform FAQs Does Mochi Health have weight loss services in Texas
Studies examining body composition changes during GLP-1 therapy, including the STEP trials (semaglutide) and SURMOUNT-1 (tirzepatide), have demonstrated that approximately 2540% of total weight lost may come from lean body mass, including skeletal muscle, rather than exclusively from fat mass